Navigation Links
Amgen's Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
Date:7/26/2012

es, excluding the impact of the Puerto Rico excise tax, increased 0.4 points to 13.9 percent of sales driven primarily by product mix, offset partially by higher average net sales prices and lower royalties.
  • R&D expenses were flat.  Expenses in support of our later-stage clinical programs increased, driven by AMG 145 and AMG 785.  This increase was offset by reduced expenses associated with marketed product support and Discovery Research and Translational Sciences.
  • Selling, General & Administrative (SG&A) expenses increased 8 percent driven primarily by international expansion as well as higher ENBREL profit share expenses.
  • ENBREL profit share expenses increased 11 percent to $371 million in the second quarter.  
  • $Millions, except percentagesOn an Adjusted BasisQ2 '12Q2 '11YOY ΔCost of Sales

    $668$56917%% of sales15.9%14.6%1.3 pts% of sales (Excluding PR excise tax)13.9%13.5%0.4 ptsResearch & Development (R&D)

    $807$8080%% of sales19.2%20.8%(1.6) ptsSelling, General & Administrative (SG&A)

    $1,199$1,1118%% of sales28.5%28.5%0 ptsTOTAL Operating Expenses$2,674$2,4887%pts: percentage points

     

  • Tax Rate increased by 0.8 points to 16.0 percent due primarily to the expiry of the U.S. federal R&D tax credit at the end of 2011.  As of June 30, 2012, the R&D tax credit had not been extended. 
  • On an Adjusted BasisQ2 '12Q2 '11YOY ΔTax Rate

    16.0%15.2%0.8 ptsTax Rate (Excluding PR excise tax)

    20.6%20.3%0.3 ptspts: percentage pointsCash Flow and Balance Sheet Discussion

  • The Company generated $2.2 billion of free cash flow in the quarter versus $1.4 billion in the second quarter of 2011. The increase was primarily driven by the termination of fixed to floating interest rate swap agreements that resulted in receipt of $0.4 billion in cash, and by the collection of $0.2 billion of outstanding tr
    '/>"/>

  • SOURCE Amgen
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Rapid Fire Marketing Funds Development of Second Generation Vapor Inhaler
    2. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
    3. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Second Quarter Financial Results And Conference Call
    4. The Female Health Company Reports Second Quarter Operating Results
    5. Winner Medical Group Inc. to Host Second Quarter 2012 Earning Conference Call on Thursday, May 10, 2012 at 9:00 p.m. EDT
    6. Biodel to Report Second Quarter Fiscal Year 2012 Financial Results on May 10, 2012
    7. Landauer, Inc. Reports Fiscal 2012 Second Quarter Results
    8. Elsevier Launches Second Annual Mosbys Superheroes of Nursing Contest During Nurses Week 2012
    9. BD and Heart to Heart International Collaborate on Second Volunteer Service Trip to Help Improve Healthcare in Haiti
    10. HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs Second Generation HIV Vaccine
    11. Johnson & Johnson Expects to Incur Special Charge in Second Quarter for Previously Disclosed Legal Matters
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/22/2014)... 2014   Surefire Medical , Inc., the developer ... maximize targeted delivery of embolization agents in minimally invasive ... John R. Daniels , MD of the University ... oncologist Steven C. Katz , MD of the ... Advisory Board (SAB).    "The role of ...
    (Date:10/22/2014)... Oct. 22, 2014 Provectus Biopharmaceuticals, Inc. (NYSEMKT: ... its novel investigational drug for cancer, is designed for ... side effects. Its oncology focus is on melanoma, breast ... phase 2 trials of PV-10 as a therapy for ... for atopic dermatitis and psoriasis. This ...
    (Date:10/20/2014)... Calif. , Oct. 20, 2014  PneumRx, Inc. ... interventional pulmonology, today announced completion of enrollment in their ... RENEW Clinical Study is the FDA-approved IDE pivotal trial ... severe emphysema. It was anticipated that the ... February 2013, would take until the end of 2014 ...
    Breaking Medicine Technology:Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2PneumRx Completes RENEW Pivotal Trial Enrollment 2PneumRx Completes RENEW Pivotal Trial Enrollment 3
    ... experts recommend annual influenza vaccination for nearly 250 million ... rates fall far short every year. According to the ... 28,842 to 115,368 Denver residents will suffer from influenza ... immunization, the American Lung Association in Colorado (ALAC) is ...
    ... Oct. 15 Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ... underwritten public offering. Prior to closing, the underwriters exercised ... shares of common stock. As a result, Savient sold ... at a price to the public of $13.29 per ...
    Cached Medicine Technology:American Lung Association in Colorado's Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver 2American Lung Association in Colorado's Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver 3American Lung Association in Colorado's Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver 4Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option 2
    (Date:10/22/2014)... MA (PRWEB) October 22, 2014 ... new solutions for the treatment of bacterial infections, microbial ... Sinskey has joined its board of directors. , ... and Engineering Systems at The Massachusetts Institute of Technology, ... MIT faculty since 1968. Dr. Sinskey also holds positions ...
    (Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 (HealthDay ... to increased blood pressure, according to a new study. ... pressure for young adult women or for teenagers, according to ... or moderately, their risk of high blood pressure was cut ... in older adult men and women," said lead researcher Dr. ...
    (Date:10/22/2014)... By Dennis Thompson HealthDay ... freelance cameraman who was diagnosed with Ebola while working for ... system and can leave the special isolation unit at Nebraska Medical ... two weeks, the hospital said Tuesday. A blood test confirmed ... Ashoka Mukpo, 33, can head home to Providence, R.I., NBC ...
    (Date:10/20/2014)... Wakefield, MA (PRWEB) October 20, 2014 ... be sponsoring a booth at the American Foundation for ... October 25th. The AFSP is a not-for-profit organization that ... year. Net proceeds from these events are used to ... research, but education and personal relationships as well. ...
    (Date:10/20/2014)... (PRWEB) October 20, 2014 hc1.com ... a secure cloud solution that enables healthcare organizations ... the ultimate healthcare-specific customer relationship management (“CRM”) solution. ... the unique needs of the healthcare industry, the ... for providers and patients by combining healthcare CRM, ...
    Breaking Medicine News(10 mins):Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2
    ... Feb. 17 Cardinal Health today,announced it has reached ... amended consent decree regarding the company,s infusion pump products. ... under a consent decree since February 2007,for its Alaris(R) ... new,quality system on April 2, 2008. Under the amended ...
    ... hearing today in Superior Court in Camden, N.J., the Honorable ... Virtua to stop its Top Doc advertising campaign. The restraining ... response to a complaint by Cooper University Hospital. In entering ... that state it has the most Top Docs in South ...
    ... study shows , , TUESDAY, Feb. 17 (HealthDay News) -- ... people with this disease to also develop neurological, cognitive and ... of the liver, which kills 25,000 people in Unites States ... C. , The disorder occurs when the liver is ...
    ... to the TV sitcom where the wife experiencing strong labor ... women rarely give birth alone. There are typically doctors, nurses ... relatives and friends. Midwives often are called on to help ... around for millennia, possibly dating as far back as 5 ...
    ... to discuss the current debate on United States, embryonic ... fellows Neal Lane and Kirstin Matthews released policy recommendations ... recommend that stem cell research be allowed to expand ... a federal stem cell policy be developed. They encourage ...
    ... WellPoint, Inc.,(NYSE: WLP ) today announced that ... on Tuesday, February 24, 2009. The meeting will be ... of WellPoint, Inc.,and will feature several presentations by the ... The event is scheduled to begin at 8:00 a.m. ...
    Cached Medicine News:Health News:Cardinal Health, FDA Amend Infusion Pump Consent Decree 2Health News:Virtua Permitted to Continue Top Docs Ad Campaign 2Health News:Anthropologist's studies of childbirth bring new focus on women in evolution 2Health News:Anthropologist's studies of childbirth bring new focus on women in evolution 3Health News:WellPoint Announces Webcast of its Conference with Investment Community 2